Quizo, Renato R.

HRN: 24-07-39  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/14/2023
12/20/2023
IV
2.25gm
Q6
Uti
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: